Alzheimer is a normal aging process that can be slowed down

Using natural healing ways, Alzheimer ‘s progression can be slowed down. It is also called Type 3 Diabetes. Is gut microbiome the culprit? Strengthen our cells with whole foods rich in omega 3, Vitamin B, A , D and C , calcium and magnesium, digestive enzymes from papaya and pineapple and pickled veggies.

Dancing, exercise, listening to music and hugs and kisses from love ones and friends will make us live long.

Share this:

Like this:

Using natural healing ways, Alzheimer ‘s progression can be slowed down. It is also called Type 3 Diabetes. Is gut microbiome the culprit? Strengthen our cells with whole foods rich in omega 3, Vitamin B, A , D and C , calcium and magnesium, digestive enzymes from papaya and pineapple and pickled veggies.

Dancing, exercise, listening to music and hugs and kisses from love ones and friends will make us live long.

If we can treat the root causes, we can prevent its progression 40 years later. It takes adequate sleep, prevention of chronic stress, whole foods, exercise, sunshine and lifestyle modification.

Our brain ages but we can energized it with positive energies , frequency and vibration. Google it and this site about the brain, memory, aging, whole foods , sleep, trauma, stress, toxins and other keywords.

I was fortunate enough to sit down with Dr. Joseph Mercola recently to discuss the topic of Alzheimer’s prevention, an area of research about which I’m very passionate. If you’ve read Grain Brain already, you should be sure to listen, as this interview dives deeper into the arguments I make in the book.

Here is a new article on Dr. Mercola’s website supporting the use of coconut oil for Alzheimer’s. There is … See more of Coconut oil helps Alzheimer’s, dementia, ALS, MS on Facebook … Discover how a tablespoon of peanut butter and an intake of coconut oil may help in the diagnosis and prevention ofAlzheimer’s disease.

Jan 8, 2018 – Pfizer has announced plans to end its research efforts to discover new drugs forAlzheimer’s and Parkinson’s diseases. The pharmaceutical giant explained its decision, which will entail roughly 300 layoffs, as a move to better position itself “to bring new therapies to patients who need them.” “As a result of a …

Jan 7, 2018 – NEW YORK (Reuters) – Pfizer Inc (PFE.N) is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company announced on Saturday. … Pfizer is not making any changes to research and development funding for tanezumab …

Jan 13, 2018 – Pfizer was heavily invested in Parkinson’s and Alzheimer’s research, and was part of the Dementia Discovery Fund, launched in 2015 with GlaxoSmithKline and Eli Lilly as a partnership between industry and government groups to develop treatments for the diseases. The Pfizerneuroscience group …

Jan 16, 2018 – The pharmaceutical company Pfizer (pfe, -0.74%), perhaps best known for its erectile dysfunction drug Viagra, recently announced that it will shut down its research and development efforts related to neurological disorders, particularly Alzheimer’s and Parkinson’s. The company says that this decision will …

Jan 8, 2018 – Despite promises that the big GOP corporate tax cut would lead to more corporate investment, Pfizer is steering $10 billion to its shareholders and ending its investment in Alzheimer’sresearch.

Jan 8, 2018 – Pfizer, one of the world’s largest drug companies, announced over the weekend that it would stop work on new drugs to fight Alzheimer’s disease and Parkinson’s disease. The reason?Pfizer believes that research on the two diseases doesn’t make sense financially.

Jan 6, 2018 – Pfizer Inc. PFE 0.36% on Saturday said it would stop trying to discover new drugs forAlzheimer’s disease and Parkinson’s disease, abandoning costly but futile efforts to find effective treatments for the disorders. The cutback will result in layoffs of 300 employees in Cambridge and Andover in Massachusetts …

Jan 9, 2018 – Pfizer, the world’s third largest drug maker, has announced it is ending research to discover new medications for Alzheimer’s and Parkinson’s disease. The move, which will eliminate hundreds of research positions across the pharmaceutical giant’s roster, casts an even darker shadow outside the company …

Jan 15, 2018 – Now some in the industry are starting to question how long that commitment can last, after Pfizer announced last week it was pulling out of neuroscience research. Its decision means the race to find the first medicine to slow or halt Alzheimer’s must now proceed without one of the biggest forces in drug …

Like this:

Published by connie dello buono

Health educator, author and enterpreneur motherhealth@gmail.com or conniedbuono@gmail.com ; cell 408-854-1883
Helping families in the bay area by providing compassionate and live-in caregivers for homebound bay area seniors. Blogs at www.clubalthea.com
Currently writing a self help and self cure ebook to help transform others in their journey to wellness, Healing within, transform inside and out. This is a compilation of topics Connie answered at quora.com and posts in this site.
View all posts by connie dello buono